In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included.
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help…
Nature Biomedical Engineering – A commercial near-infrared dye that is sensitive to apoptosis and that provides high tumour-to-muscle and tumour-to-liver contrast ratios facilitates…
In this interview, hematologic oncologist Eytan Stein, Director of the Program for Drug Development in Leukemia, talks about the latest advances in treatment for AML…
Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan…
Since 2019, MSK has been pioneering the use of robotic surgery for resecting complex, benign paraspinal tumors.
Welcome! You are invited to join a meeting: MSKCC Fellowship Programs Open House. After registering, you will receive a confirmation email about joining the meeting.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
New MSK research uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals…
Abstract. Intra-tumoral heterogeneity in pancreatic ductal adenocarcinoma (PDAC) is characterized by a balance between basal and classical epithelial cancer cell states, with basal dominance associating…
